|
Registration Successful. Thank you for registering.
We have emailed a password to
Please check your email, enter the password we've sent you and click LOGIN to continue.
|
|
You need to be logged on as a free registered user or subscriber for this link.
Please log in or see below for free registration, subscription or free trial.
|
|
You need a premium subscription for this link to work.
Please see below for free registration, premium subscription or free trial.
|
|
|
(For free registration, leave blank and click Login) |
|
|
| Forgotten your password? |
|
| Having trouble with this screen? Email us or phone 011-728-5510 |
|
 |
|
Need a password? Registration is FREE!
Just enter an email address above and click the LOGIN button (leave the password field blank) |
|
| |
| | Free registration is required to access customise options, watchlists, portfolios and the alert service so that we can protect your privacy and keep track of your selections. We undertake never to abuse your email address.
If you are an ex-subscriber, free trial user or newsletter recipient you are automatically a free user – just click here and we'll email you a password reminder.
If you've never registered before, enter an email address above (leave password field blank) and click LOGIN - we'll send you a password immediately. |
| |
|
|
|
Need a subscription?
Take the inside track, become a PREMIUM user |
|
| Subscribers to ShareData Online have access to professional-level information – the same data used by financial markets specialists and fund managers. Subscription rates for private investors are very reasonable – the equivalent of a weekly grande latte. |
| |
| Click here for the subscription sign-up page |
|
|
|
|
Or sign up for a free trial...
Full access for 10 days, no strings attached |
|
| | If you'd like to preview our PREMIUM content, please sign up for a free trial. |
| |
| | We do NOT ask for credit card details. At the end of the free trial, if you choose not to subscribe, you will automatically be a free registered user with access to watchlists, portfolios and alerts. |
| |
| | The free trial gives full access to all of ShareData Online for 10 days. |
| |
| | Please click here for the free trial sign-up page. |
|
Email address
When you click the 'Send' button an email will be sent to the above email address
containing the password that is registered for the email address.
ShareData Online is currently in use on another computer that logged in with the email address .
That computer last accessed ShareData Online on .
To use ShareData Online on this computer do one of the following:
- Select Logoff from the Admin menu on the other computer
- Or wait for 1 hour of no activity on the other computer
For more information see the Conditions of Subscription in the Terms of Use for ShareData Online.
"Each login and password is provided for the exclusive use of a single
individual for use on a single workstation per login. The Subscriber undertakes
that each login shall be used by one individual on one computer, workstation or
device at a time, and further undertakes not to disclose login details to other
persons."
|
|
|
|
|
|
|
|
| Add DCP to |
|
Watch List |
|
|
|
| Add DCP to |
|
Portfolio |
|
|
|
|
|
| Fri 30 May 2025, 7:46 | | Dis-Chem final results February 2025 |
| View SENS |
Revenue from contracts with customers rose to R39.2 billion (R36.3 billion) with gross profit ending higher on R8.8 billion (R8.2 billion). Operating profit before interest and equity accounted earnings increased to R2.1 billion (R1.8 billion) and total profit attributable to equity holders of the parents leaped to R1.2 billion (R984.5 million). Additionally, headline earnings per share inclined to 137.5c per share (114.6c per share).
Dividend declaration
Notice was given that a gross final cash dividend of 27.85196 cents per share, in respect of the period ended 28 February 2025 has been declared based on the company's dividend policy of 40% of headline earnings.
Directorate
No changes have been made to the board since period-end or the prior corresponding period.
Company outlook
For the three-month period 1 March 2025 to 27 May 2025, Group revenue grew by 8.6% over the comparable period.
• Retail revenue grew by 7.8%, supported by the opening of nine pharmacy stores, with comparable pharmacy store revenue growth at 4.6%.
• Wholesale revenue to external customers grew by 13.6%.
The Group expects that the consumer will remain constrained due to the current economic climate. Following the establishment of X, bigly labs, the Group's innovation hub, there's a shift to data-led commercial decisioning that places the customer at the centre of the ecosystem experience.
Linked to our strategic areas of focus, the following business priorities will progress and launch in FY2026.
• Continued acceleration of space identification and new store openings towards achieving the three-year target of 137,000m². Including the 9 stores already trading in FY2026, 39 retail pharmacy stores are planned for the year.
• Store of the future design to facilitate true omnichannel retailing and healthcare delivery, incorporating ecosystem elements aligned to brand architecture
• Evolve and simplify promotional mechanisms following the relaunch of our loyalty programme in 2H FY2026
• Deployment of staffing framework 2.0 into the retail business
• R500 million working capital unlock
• Reimagine online retailing and healthcare access, starting with complete revamp of digital channels
• Build increased customer engagement with enhanced value creation driving customer lifetime value across the ecosystem
• Establishment of strategic partnerships with brands that are non-industry competitive to provide access to mass market South Africa
• People and Culture: employees as our priority customers with a commitment to improve their health enabling them to access differentiated rewards, creating 20,000 purpose-aligned ambassadors delivering on the ecosystem strategy |
|
|
|
|